Screener
Xeris Biopharma Holdings, Inc. XERS Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s operating lease liabilities (current)?
- Xeris Biopharma Holdings, Inc. (XERS) reported operating lease liabilities (current) of $6.31M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s operating lease liabilities (current) changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s operating lease liabilities (current) increased by 2.5% year-over-year, from $6.16M to $6.31M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Xeris Biopharma Holdings, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude